SlideShare a Scribd company logo
1 of 22
CASE BASED
LEARNING
AF
Jane Nader, MD
• A 74-year-old woman presents for her annual physical examination and notes increasing
fatigue over the prior 3 months.
• Her history is notable for longstanding, but well-controlled, systolic hypertension.
• A physical examination demonstrates a blood pressure of 120/70 mm Hg and an irregular
pulse of approximately 120 bpm at rest.
• The patient weighs 60 KG with a body mass index of 22.
• The rest of her examination is completely normal with no clinical evidence of right- or
left-sided heart failure.
• The patient has no family history of coronary artery disease, cardiomyopathy or atrial
fibrillation.
• Her review of systems is notable only for fatigue without complaint of snoring, chest pain,
palpitations, weight gain or loss, orthopnea, dyspnea, peripheral edema or syncope.
• .
• .
• .
• .
• .
• .
• .
• .
• .
• A 74-year-old woman presents for her annual physical examination and notes increasing
fatigue over the prior 3 months.
• Her history is notable for longstanding, but well-controlled, systolic hypertension.
• A physical examination demonstrates a blood pressure of 120/70 mm Hg and an irregular
pulse of approximately 120 bpm at rest.
• The patient weighs 60 KG with a body mass index of 22.
• The rest of her examination is completely normal with no clinical evidence of right- or
left-sided heart failure.
• The patient has no family history of coronary artery disease, cardiomyopathy or atrial
fibrillation.
• Her review of systems is notable only for fatigue without complaint of snoring, chest pain,
palpitations, weight gain or loss, orthopnea, dyspnea, peripheral edema or syncope.
Q. What investigations should you order
for this patient?
Tests including complete blood count, electrolytes, HbA1c
and liver function to eliminate potential causes of fatigue
were within normal limits.
An confirms the diagnosis of atrial fibrillation with a
rapid ventricular response of 120 bpm and criteria for left
ventricular hypertrophy.
o An done a year earlier to evaluate left ventricular
hypertrophy was notable only for mild, global left ventricular
dysfunction with a left ventricular ejection fraction of 40% and
mild mitral regurgitation.
o A subsequent showed no evidence of myocardial
ischemia.
o The patient’s includes lisinopril 20 mg, metoprolol XL
25 mg and 81 mg aspirin daily.
A repeat performed in the office demonstrates an ejection
fraction of 20% but normal left ventricular dimensions with normal
pulmonary arterial systolic pressure.
BEFORE
NOW
The primary goals of AF management include symptom
relief and thromboembolic prophylaxis.
The acute management of this patient should be centered
first on symptom relief in the form of improved rate
control to reduce the resting heart rate to less than
110 bpm.
Digoxin is less effective for rate control than beta-
blockers or calcium-channel blockers (e.g., verapamil
or diltiazem), but it can be considered if blood
pressure is low.
9
Clinical Questions
This is a common clinical scenario that raises a number of
important management questions
Q. Should you restore sinus rhythm or choose a
strategy of rate control?
Rate vs. Rhythm Control
In this patient case, the presence of worsened left
ventricular function is likely the result of
tachycardia and necessitates aggressive rate control in
the short term.
The condition is a reasonable justification to attempt
restoration of sinus rhythm with the hope that left
ventricular function will return to normal.
If the decision is made to maintain sinus rhythm after the
cardioversion, what are the best medical or procedural options?
Q. What are the anticoagulation
requirements for this patient?
Recommendations for chronic anticoagulation in patients with AF are
determined by clinical risk factors such as
History of congestive heart failure
Hypertension
Age older than 64 OR 75
Diabetes mellitus
Past stroke or TIA
Female sex
Vascular disease
In this case the risk factors for
stroke:
including sex
age
hypertension
All together mandate chronic anticoagulation regardless of the
decision for rhythm or rate control.
The choices for anticoagulation include warfarin with a target INR
of ? or NOACs
In this case the risk factors for
stroke:
including sex
age
hypertension
In this case dabigatran was initiated.
The decision for Rate control was made with an increased
dose of metoprolol but was limited by hypotension.
20
As a consequence, a TEE (trans-esophageal echo) was
performed to exclude an existing thrombus and allow
cardioversion.
The procedure demonstrated a clear left atrium and this
allowed DC cardioversion to be performed safely.
Choice of anti-arrhythmic drugs
according to cardiac condition
Digoxin Digoxin
THANK YOU

More Related Content

Similar to Tachyarrhythmia Case Based Group Discussion.pptx

Cardiology morning presentation to internal medicine2232018 final
Cardiology morning presentation to internal medicine2232018 finalCardiology morning presentation to internal medicine2232018 final
Cardiology morning presentation to internal medicine2232018 final
hospital
 
Persistent Atrial Fibrillation Management: Case preventation
Persistent Atrial Fibrillation Management: Case preventationPersistent Atrial Fibrillation Management: Case preventation
Persistent Atrial Fibrillation Management: Case preventation
salah_atta
 
Anaesthetic management of Abdominal aortic aneurysms
Anaesthetic management of Abdominal aortic aneurysmsAnaesthetic management of Abdominal aortic aneurysms
Anaesthetic management of Abdominal aortic aneurysms
Abhijit Nair
 

Similar to Tachyarrhythmia Case Based Group Discussion.pptx (20)

Severly Elevated Blood Pressure : Dr Peter Andre Soltau
Severly Elevated Blood Pressure :  Dr Peter Andre SoltauSeverly Elevated Blood Pressure :  Dr Peter Andre Soltau
Severly Elevated Blood Pressure : Dr Peter Andre Soltau
 
Cardiology morning presentation to internal medicine2232018 final
Cardiology morning presentation to internal medicine2232018 finalCardiology morning presentation to internal medicine2232018 final
Cardiology morning presentation to internal medicine2232018 final
 
Anticoagulation therapy for atrial fibrillation
Anticoagulation therapy for atrial fibrillationAnticoagulation therapy for atrial fibrillation
Anticoagulation therapy for atrial fibrillation
 
Atrial fibrilation diagnosis and management updated guidline. NICE 2021.
Atrial fibrilation diagnosis and management updated guidline. NICE 2021.Atrial fibrilation diagnosis and management updated guidline. NICE 2021.
Atrial fibrilation diagnosis and management updated guidline. NICE 2021.
 
Dr. Siegfried
Dr. SiegfriedDr. Siegfried
Dr. Siegfried
 
Congestive Heart Failure Case Presentation
Congestive Heart Failure Case PresentationCongestive Heart Failure Case Presentation
Congestive Heart Failure Case Presentation
 
Management of atrial fibrillation (summary)
Management of atrial fibrillation (summary)Management of atrial fibrillation (summary)
Management of atrial fibrillation (summary)
 
Hypertension Emergencies and their managementpptx
Hypertension Emergencies and their managementpptxHypertension Emergencies and their managementpptx
Hypertension Emergencies and their managementpptx
 
Approach to a patient with resistant hypertension
Approach to a patient with resistant hypertensionApproach to a patient with resistant hypertension
Approach to a patient with resistant hypertension
 
Atrial fibrilation
Atrial fibrilationAtrial fibrilation
Atrial fibrilation
 
HEART DISEASE & PREGNANCY.pptx
HEART DISEASE & PREGNANCY.pptxHEART DISEASE & PREGNANCY.pptx
HEART DISEASE & PREGNANCY.pptx
 
Mixed results for heart failure therapies, journel club
Mixed results for heart failure therapies, journel clubMixed results for heart failure therapies, journel club
Mixed results for heart failure therapies, journel club
 
Atrial fibrillation presentation-1.pptx
Atrial fibrillation presentation-1.pptxAtrial fibrillation presentation-1.pptx
Atrial fibrillation presentation-1.pptx
 
Persistent Atrial Fibrillation Management: Case preventation
Persistent Atrial Fibrillation Management: Case preventationPersistent Atrial Fibrillation Management: Case preventation
Persistent Atrial Fibrillation Management: Case preventation
 
Anaesthetic management of Abdominal aortic aneurysms
Anaesthetic management of Abdominal aortic aneurysmsAnaesthetic management of Abdominal aortic aneurysms
Anaesthetic management of Abdominal aortic aneurysms
 
Aortic stenosis
Aortic stenosisAortic stenosis
Aortic stenosis
 
Dapa HF trial.pptx
Dapa HF trial.pptxDapa HF trial.pptx
Dapa HF trial.pptx
 
hypertensive crisis.pptx
hypertensive crisis.pptxhypertensive crisis.pptx
hypertensive crisis.pptx
 
Pre op clearance for elderly patients
Pre op clearance for elderly patientsPre op clearance for elderly patients
Pre op clearance for elderly patients
 
EVALUATION OF ATRIAL FIBRILLATION-1.pdf
EVALUATION OF ATRIAL  FIBRILLATION-1.pdfEVALUATION OF ATRIAL  FIBRILLATION-1.pdf
EVALUATION OF ATRIAL FIBRILLATION-1.pdf
 

More from Jane390174

Arrhythmogenic Right Ventricular Dysrhythmias.pptx
Arrhythmogenic Right Ventricular Dysrhythmias.pptxArrhythmogenic Right Ventricular Dysrhythmias.pptx
Arrhythmogenic Right Ventricular Dysrhythmias.pptx
Jane390174
 

More from Jane390174 (11)

Cardiology Simple Revision, DR. Jane Nader
Cardiology Simple Revision, DR. Jane NaderCardiology Simple Revision, DR. Jane Nader
Cardiology Simple Revision, DR. Jane Nader
 
Tachyarrhythmia short case Dr. Jane Nader
Tachyarrhythmia short case Dr. Jane NaderTachyarrhythmia short case Dr. Jane Nader
Tachyarrhythmia short case Dr. Jane Nader
 
Tachyarrhythmia Lecture. Doctor/ Jane Nader
Tachyarrhythmia Lecture. Doctor/ Jane NaderTachyarrhythmia Lecture. Doctor/ Jane Nader
Tachyarrhythmia Lecture. Doctor/ Jane Nader
 
Bradycardias & heart block Jane Nader.pdf
Bradycardias & heart block Jane Nader.pdfBradycardias & heart block Jane Nader.pdf
Bradycardias & heart block Jane Nader.pdf
 
Cardiac Tumors for medical students Jane Nader
Cardiac Tumors for medical students Jane NaderCardiac Tumors for medical students Jane Nader
Cardiac Tumors for medical students Jane Nader
 
ECHOcardiography WORKSHOP dr Jane Nader.pdf
ECHOcardiography WORKSHOP dr Jane Nader.pdfECHOcardiography WORKSHOP dr Jane Nader.pdf
ECHOcardiography WORKSHOP dr Jane Nader.pdf
 
Case Discussion in Cardiomyopathy for students.pptx
Case Discussion in Cardiomyopathy for students.pptxCase Discussion in Cardiomyopathy for students.pptx
Case Discussion in Cardiomyopathy for students.pptx
 
Arrhythmogenic Right Ventricular Dysrhythmias.pptx
Arrhythmogenic Right Ventricular Dysrhythmias.pptxArrhythmogenic Right Ventricular Dysrhythmias.pptx
Arrhythmogenic Right Ventricular Dysrhythmias.pptx
 
Cardiomyopathy Edited for medical students.pptx
Cardiomyopathy Edited for medical students.pptxCardiomyopathy Edited for medical students.pptx
Cardiomyopathy Edited for medical students.pptx
 
Skill ECG (2) arrhythmia for students.pptx
Skill ECG (2) arrhythmia for students.pptxSkill ECG (2) arrhythmia for students.pptx
Skill ECG (2) arrhythmia for students.pptx
 
Skill ECG (1) Ischemia for students .pptx
Skill ECG (1) Ischemia for students .pptxSkill ECG (1) Ischemia for students .pptx
Skill ECG (1) Ischemia for students .pptx
 

Recently uploaded

Difference Between Skeletal Smooth and Cardiac Muscles
Difference Between Skeletal Smooth and Cardiac MusclesDifference Between Skeletal Smooth and Cardiac Muscles
Difference Between Skeletal Smooth and Cardiac Muscles
MedicoseAcademics
 
Unit 4 Pharmaceutical Organic Chemisty 3 Quinoline
Unit 4 Pharmaceutical Organic Chemisty 3 QuinolineUnit 4 Pharmaceutical Organic Chemisty 3 Quinoline
Unit 4 Pharmaceutical Organic Chemisty 3 Quinoline
AarishRathnam1
 
Failure to thrive in neonates and infants + pediatric case.pptx
Failure to thrive in neonates and infants  + pediatric case.pptxFailure to thrive in neonates and infants  + pediatric case.pptx
Failure to thrive in neonates and infants + pediatric case.pptx
claviclebrown44
 
VIII.1 Nursing Interventions to Promote Healthy Psychological responses, SELF...
VIII.1 Nursing Interventions to Promote Healthy Psychological responses, SELF...VIII.1 Nursing Interventions to Promote Healthy Psychological responses, SELF...
VIII.1 Nursing Interventions to Promote Healthy Psychological responses, SELF...
JRRolfNeuqelet
 

Recently uploaded (20)

Top 10 Most Beautiful Russian Pornstars List 2024
Top 10 Most Beautiful Russian Pornstars List 2024Top 10 Most Beautiful Russian Pornstars List 2024
Top 10 Most Beautiful Russian Pornstars List 2024
 
Histopathological staining techniques used in liver diseases
Histopathological staining techniques used in liver diseasesHistopathological staining techniques used in liver diseases
Histopathological staining techniques used in liver diseases
 
Difference Between Skeletal Smooth and Cardiac Muscles
Difference Between Skeletal Smooth and Cardiac MusclesDifference Between Skeletal Smooth and Cardiac Muscles
Difference Between Skeletal Smooth and Cardiac Muscles
 
seventh section physiology laboratory.pptx
seventh section physiology laboratory.pptxseventh section physiology laboratory.pptx
seventh section physiology laboratory.pptx
 
JOURNAL CLUB PRESENTATION TEMPLATE DOCUMENT
JOURNAL CLUB PRESENTATION TEMPLATE DOCUMENTJOURNAL CLUB PRESENTATION TEMPLATE DOCUMENT
JOURNAL CLUB PRESENTATION TEMPLATE DOCUMENT
 
Drug development life cycle indepth overview.pptx
Drug development life cycle indepth overview.pptxDrug development life cycle indepth overview.pptx
Drug development life cycle indepth overview.pptx
 
Unit 4 Pharmaceutical Organic Chemisty 3 Quinoline
Unit 4 Pharmaceutical Organic Chemisty 3 QuinolineUnit 4 Pharmaceutical Organic Chemisty 3 Quinoline
Unit 4 Pharmaceutical Organic Chemisty 3 Quinoline
 
Unlocking Holistic Wellness: Addressing Depression, Mental Well-Being, and St...
Unlocking Holistic Wellness: Addressing Depression, Mental Well-Being, and St...Unlocking Holistic Wellness: Addressing Depression, Mental Well-Being, and St...
Unlocking Holistic Wellness: Addressing Depression, Mental Well-Being, and St...
 
Failure to thrive in neonates and infants + pediatric case.pptx
Failure to thrive in neonates and infants  + pediatric case.pptxFailure to thrive in neonates and infants  + pediatric case.pptx
Failure to thrive in neonates and infants + pediatric case.pptx
 
VIII.1 Nursing Interventions to Promote Healthy Psychological responses, SELF...
VIII.1 Nursing Interventions to Promote Healthy Psychological responses, SELF...VIII.1 Nursing Interventions to Promote Healthy Psychological responses, SELF...
VIII.1 Nursing Interventions to Promote Healthy Psychological responses, SELF...
 
Sell 5cladba adbb JWH-018 5FADB in stock
Sell 5cladba adbb JWH-018 5FADB in stockSell 5cladba adbb JWH-018 5FADB in stock
Sell 5cladba adbb JWH-018 5FADB in stock
 
Unveiling Alcohol Withdrawal Syndrome: exploring it's hidden depths
Unveiling Alcohol Withdrawal Syndrome: exploring it's hidden depthsUnveiling Alcohol Withdrawal Syndrome: exploring it's hidden depths
Unveiling Alcohol Withdrawal Syndrome: exploring it's hidden depths
 
How to buy 5cladba precursor raw 5cl-adb-a raw material
How to buy 5cladba precursor raw 5cl-adb-a raw materialHow to buy 5cladba precursor raw 5cl-adb-a raw material
How to buy 5cladba precursor raw 5cl-adb-a raw material
 
Overview on the Automatic pill identifier
Overview on the Automatic pill identifierOverview on the Automatic pill identifier
Overview on the Automatic pill identifier
 
ESC HF 2024 Spotlights Day-2.pptx heart failure
ESC HF 2024 Spotlights Day-2.pptx heart failureESC HF 2024 Spotlights Day-2.pptx heart failure
ESC HF 2024 Spotlights Day-2.pptx heart failure
 
Anti viral drug pharmacology classification
Anti viral drug pharmacology classificationAnti viral drug pharmacology classification
Anti viral drug pharmacology classification
 
BURNS (CLASSIFICATION & MANAGEMENTS).pdf
BURNS (CLASSIFICATION & MANAGEMENTS).pdfBURNS (CLASSIFICATION & MANAGEMENTS).pdf
BURNS (CLASSIFICATION & MANAGEMENTS).pdf
 
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS by Dr M.KARTHIK EMMANUEL
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS  by Dr M.KARTHIK EMMANUELCONGENITAL HYPERTROPHIC PYLORIC STENOSIS  by Dr M.KARTHIK EMMANUEL
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS by Dr M.KARTHIK EMMANUEL
 
Lachesis Mutus- a Homoeopathic medicinel.pptx
Lachesis Mutus- a Homoeopathic medicinel.pptxLachesis Mutus- a Homoeopathic medicinel.pptx
Lachesis Mutus- a Homoeopathic medicinel.pptx
 
Face and Muscles of facial expression.pptx
Face and Muscles of facial expression.pptxFace and Muscles of facial expression.pptx
Face and Muscles of facial expression.pptx
 

Tachyarrhythmia Case Based Group Discussion.pptx

  • 2. • A 74-year-old woman presents for her annual physical examination and notes increasing fatigue over the prior 3 months. • Her history is notable for longstanding, but well-controlled, systolic hypertension. • A physical examination demonstrates a blood pressure of 120/70 mm Hg and an irregular pulse of approximately 120 bpm at rest. • The patient weighs 60 KG with a body mass index of 22. • The rest of her examination is completely normal with no clinical evidence of right- or left-sided heart failure. • The patient has no family history of coronary artery disease, cardiomyopathy or atrial fibrillation. • Her review of systems is notable only for fatigue without complaint of snoring, chest pain, palpitations, weight gain or loss, orthopnea, dyspnea, peripheral edema or syncope. • . • . • . • . • . • . • . • . • .
  • 3. • A 74-year-old woman presents for her annual physical examination and notes increasing fatigue over the prior 3 months. • Her history is notable for longstanding, but well-controlled, systolic hypertension. • A physical examination demonstrates a blood pressure of 120/70 mm Hg and an irregular pulse of approximately 120 bpm at rest. • The patient weighs 60 KG with a body mass index of 22. • The rest of her examination is completely normal with no clinical evidence of right- or left-sided heart failure. • The patient has no family history of coronary artery disease, cardiomyopathy or atrial fibrillation. • Her review of systems is notable only for fatigue without complaint of snoring, chest pain, palpitations, weight gain or loss, orthopnea, dyspnea, peripheral edema or syncope.
  • 4. Q. What investigations should you order for this patient?
  • 5. Tests including complete blood count, electrolytes, HbA1c and liver function to eliminate potential causes of fatigue were within normal limits. An confirms the diagnosis of atrial fibrillation with a rapid ventricular response of 120 bpm and criteria for left ventricular hypertrophy.
  • 6. o An done a year earlier to evaluate left ventricular hypertrophy was notable only for mild, global left ventricular dysfunction with a left ventricular ejection fraction of 40% and mild mitral regurgitation. o A subsequent showed no evidence of myocardial ischemia. o The patient’s includes lisinopril 20 mg, metoprolol XL 25 mg and 81 mg aspirin daily. A repeat performed in the office demonstrates an ejection fraction of 20% but normal left ventricular dimensions with normal pulmonary arterial systolic pressure. BEFORE NOW
  • 7.
  • 8. The primary goals of AF management include symptom relief and thromboembolic prophylaxis. The acute management of this patient should be centered first on symptom relief in the form of improved rate control to reduce the resting heart rate to less than 110 bpm. Digoxin is less effective for rate control than beta- blockers or calcium-channel blockers (e.g., verapamil or diltiazem), but it can be considered if blood pressure is low.
  • 9. 9 Clinical Questions This is a common clinical scenario that raises a number of important management questions
  • 10.
  • 11. Q. Should you restore sinus rhythm or choose a strategy of rate control? Rate vs. Rhythm Control In this patient case, the presence of worsened left ventricular function is likely the result of tachycardia and necessitates aggressive rate control in the short term. The condition is a reasonable justification to attempt restoration of sinus rhythm with the hope that left ventricular function will return to normal.
  • 12. If the decision is made to maintain sinus rhythm after the cardioversion, what are the best medical or procedural options?
  • 13. Q. What are the anticoagulation requirements for this patient? Recommendations for chronic anticoagulation in patients with AF are determined by clinical risk factors such as History of congestive heart failure Hypertension Age older than 64 OR 75 Diabetes mellitus Past stroke or TIA Female sex Vascular disease
  • 14.
  • 15. In this case the risk factors for stroke: including sex age hypertension
  • 16. All together mandate chronic anticoagulation regardless of the decision for rhythm or rate control. The choices for anticoagulation include warfarin with a target INR of ? or NOACs In this case the risk factors for stroke: including sex age hypertension
  • 17. In this case dabigatran was initiated.
  • 18. The decision for Rate control was made with an increased dose of metoprolol but was limited by hypotension.
  • 19.
  • 20. 20 As a consequence, a TEE (trans-esophageal echo) was performed to exclude an existing thrombus and allow cardioversion. The procedure demonstrated a clear left atrium and this allowed DC cardioversion to be performed safely.
  • 21. Choice of anti-arrhythmic drugs according to cardiac condition Digoxin Digoxin

Editor's Notes

  1. The decision to maintain sinus rhythm or choose a strategy of rate control is generally based on how easily symptoms can be mitigated with rate control. If the rate is easily controlled, it is reasonable to forego cardioversion. Conversely if the rate is difficult to control and the patient has progressive symptoms including those of heart failure, a strategy of cardioversion and maintenance of sinus rhythm is preferred. Restoring sinus rhythm by cardioversion should be preceded by measures to reduce the risk of pericardioversion stroke, including either a transesophageal echocardiogram to exclude left atrial appendage clot or a minimum of 3 consecutive weeks of dabigatran or 3 consecutive weeks with an INR of ³ 2, if using warfarin.